Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:AALBF OTCMKTS:BVII OTCMKTS:DRWN OTCMKTS:SHTDF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAALBFAalberts$47.00$41.52$30.30▼$47.00N/AN/A841 shs59 shsBVII(BVII)$0.00$0.03▼$0.10N/AN/A3,442 shsN/ADRWNA Clean Slate$0.00$0.00▼$0.00N/A0.241 shsN/ASHTDFSinopharm Group$2.29$2.40$2.11▼$2.70N/AN/A18,475 shsN/ADon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAALBFAalberts0.00%+5.76%+10.12%+27.68%+31.14%DRWNA Clean Slate0.00%0.00%0.00%0.00%0.00%SHTDFSinopharm Group0.00%0.00%-2.67%-12.87%+4.80%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAALBFAalberts$47.00$41.52$30.30▼$47.00N/AN/A841 shs59 shsBVII(BVII)$0.00$0.03▼$0.10N/AN/A3,442 shsN/ADRWNA Clean Slate$0.00$0.00▼$0.00N/A0.241 shsN/ASHTDFSinopharm Group$2.29$2.40$2.11▼$2.70N/AN/A18,475 shsN/ADon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAALBFAalberts0.00%+5.76%+10.12%+27.68%+31.14%DRWNA Clean Slate0.00%0.00%0.00%0.00%0.00%SHTDFSinopharm Group0.00%0.00%-2.67%-12.87%+4.80%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAALBFAalberts 3.00BuyN/AN/ABVII(BVII) 0.00N/AN/AN/ADRWNA Clean Slate 0.00N/AN/AN/ASHTDFSinopharm Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SHTDF, BVII, DRWN, and AALBF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/20/2026AALBFAalberts BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight(Data available from 6/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAALBFAalbertsN/AN/AN/AN/AN/AN/ABVII(BVII)N/AN/AN/AN/AN/AN/ADRWNA Clean SlateN/AN/AN/AN/AN/AN/ASHTDFSinopharm GroupN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAALBFAalbertsN/A$1.2737.09N/AN/AN/AN/AN/A7/23/2026 (Estimated)BVII(BVII)N/AN/AN/AN/AN/AN/AN/AN/AN/ADRWNA Clean SlateN/AN/AN/AN/AN/AN/AN/AN/AN/ASHTDFSinopharm GroupN/A$1.002.29N/AN/AN/AN/AN/A8/31/2026 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAALBFAalberts$0.350.74%N/A27.50%N/ABVII(BVII)N/AN/AN/AN/AN/ADRWNA Clean SlateN/AN/AN/AN/AN/ASHTDFSinopharm Group$0.2611.37%N/A26.05%N/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAALBFAalberts46.99%BVII(BVII)N/ADRWNA Clean SlateN/ASHTDFSinopharm Group16.47%Insider OwnershipCompanyInsider OwnershipAALBFAalbertsN/ABVII(BVII)N/ADRWNA Clean Slate19.10%SHTDFSinopharm GroupN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAALBFAalberts14,055N/AN/ANot OptionableBVII(BVII)147,000N/AN/ANot OptionableDRWNA Clean Slate1N/AN/ANot OptionableSHTDFSinopharm Group115,959N/AN/ANot OptionableSHTDF, BVII, DRWN, and AALBF HeadlinesRecent News About These CompaniesSinopharm Shareholders Approve 2025 Results and Final Dividend at AGMJune 18 at 5:11 AM | tipranks.comSinopharm expands its international presenceMay 19, 2026 | chinadaily.com.cnCSinopharm posts unaudited Q1 2026 figures, highlighting RMB 400.8bn asset baseApril 26, 2026 | tipranks.comSinopharm Proposes Final Cash Dividend of RMB 0.69 per Share for 2025March 22, 2026 | tipranks.comSinopharm Group Details Board Composition and Committee RolesDecember 19, 2025 | tipranks.comHSBC Keeps Their Sell Rating on Sinopharm Group Co (SHTDF)November 14, 2025 | theglobeandmail.comSinopharm Group Reports Third Quarter 2025 Financial ResultsOctober 30, 2025 | tipranks.comSinopharm Group Reports Strong Financial Position for Nine Months Ending September 2025October 26, 2025 | tipranks.comSinopharm’s CNMDC Reports Mixed Financial Results for 2025October 23, 2025 | tipranks.comSinopharm Reports Steady Revenue Growth Amid Cash Flow Challenges in Q3 2025October 21, 2025 | tipranks.comSinopharm Accord Reports Decline in Nine-Month Financial PerformanceOctober 21, 2025 | tipranks.comSinopharm Group to Review Quarterly Financial ResultsOctober 10, 2025 | tipranks.comSinopharm Reports Decline in H1 2025 Financial PerformanceAugust 29, 2025 | tipranks.comSinopharm Group Reports Decline in 2025 Interim ResultsAugust 24, 2025 | tipranks.comSinopharm Reports Mixed Financial Results for First Half of 2025August 20, 2025 | tipranks.comMediThinQ Enters China Through Strategic Partnership with SinopharmMay 22, 2025 | en.antaranews.comEVentureBlick: MediThinQ Enters China Through Strategic Partnership with Sinopharm, Making Wearable Surgical Displays a Reality in Operating TheatresMay 20, 2025 | msn.comCoronavirus Disease 2019 (COVID-19) vaccine 2 by Sinopharm Group for Coronavirus Disease 2019 (COVID-19): Likelihood of ApprovalDecember 30, 2024 | pharmaceutical-technology.comPSinopharm Group: The Focus Is On Working Capital And ProfitabilityNovember 22, 2024 | seekingalpha.comSinopharm Group’s Asset Growth Boosts Investor ConfidenceOctober 28, 2024 | markets.businessinsider.comMedia Sentiment Over TimeSHTDF, BVII, DRWN, and AALBF Company DescriptionsAalberts OTCMKTS:AALBF$47.00 0.00 (0.00%) As of 06/18/2026Aalberts N.V. offers mission-critical technologies for aerospace, automotive, building, and maritime sectors. It operates through Building Technology and Industrial Technology sectors. The Building Technology segment develops, manufactures, and monitors hydronic flow control systems for heating and cooling to enhance the energy efficiency; and develops, designs, and manufactures integrated piping systems to distribute and regulate water or gas flows in heating, cooling, water, gas, and sprinkler systems in eco-friendly buildings and industrial niches. The Industrial Technology segment co-develops, engineers, and manufactures advanced mechatronics and technologies to regulate, measure, and control fluids under severe and critical conditions for active OEMs in semicon efficiency, sustainable transportation, and industrial niches; and offers a range of surface technologies utilizing a network of service locations local knowledge to customers active in sustainable transportation and industrial niches. It operates in Western Europe, the United States, Russia, Eastern Europe, the Asia-Pacific, the Middle East, and Africa. The company was formerly known as Aalberts Industries N.V. and changed its name to Aalberts N.V. in April 2019. Aalberts N.V. was founded in 1975 and is headquartered in Utrecht, the Netherlands.(BVII) OTCMKTS:BVIIBroadview Institute, Inc. is a career-focused post-secondary education services company. The Company operates primarily through its subsidiary, C Square Educational Enterprises, Inc. (Broadview University). Broadview University has campuses located in the Utah cities of Layton, Orem, Salt Lake City and West Jordan, as well as Boise, Idaho. Broadview University is accredited by the Accrediting Council for Independent Colleges and Schools (ACICS) to award diplomas, undergraduate degrees, and master's degrees in various fields of study. The Company's admissions department interviews potential applicants, provides information regarding its academic programs, and assists with the overall application process. The Company helps its students to complete their program of study through admissions screening, financial planning and student services. The Company's classes are offered in the day and evening, and many courses are available through online delivery. It also provides assistance.A Clean Slate OTCMKTS:DRWNQuantum Medical Transport, Inc., doing business as Quantum Medical Data Services, operates as a medical blockchain data services company. It is developing a medical blockchain technology for secure data storage and data transfer. The company was formerly known as A Clean Slate, Inc. and changed its name to Quantum Medical Transport, Inc. in August 2015. Quantum Medical Transport, Inc. is based in Sugar Land, Texas.Sinopharm Group OTCMKTS:SHTDF$2.29 0.00 (0.00%) As of 06/18/2026Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/15 - 06/19 Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Why Kroger’s Pullback Could Be a Gift for Patient Investors Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Why Palantir’s Google Cloud Deal Could Change the Debate VMware: Broadcom's Second Biggest Business Set to Accelerate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
